It is almost a year since the Pfizer-BioNTech SARS-CoV-2 vaccine has been made available by the FDA under emergency use authorization (EUA). The question still being asked is whether the vaccine is safe for people with lupus?
All News
Article
Article
How to best book patient appointments in rheumatology clinic? Should these be scheduled every 3 or 4 months regardless of patient status? Should they be scheduled by patient need or disease activity?
Article
Surely you’ve seen this or been plagued by this patient, one that is not doing well, in need of a new regimen; you outline it, timeline it, define the side effects and send them off with a new prescription..
COVID-19 Vaccination in Autoimmune Disease: Dr. Sheila Reyes ( @RHEUMarampa) interviews Dr. Latika Gupta about abstract #0444, presented at the #ACR21 annual meeting.
https://t.co/yFqj3fAtrW https://t.co/idWis7FURI
Data on Existing SLE Medications, Patient Centered Outcomes, and Exercise: Dr. Michelle Petri discusses data on existing SLE medications, patient-centered outcomes and the importance of exercise, presented Monday at the #ACR21 annual meeting.
https://t.co/iADDiasPZf https://t.co/r84eUtzbcb
Long Term Steroid Use in RA - Matters of the Heart: Dr. Mrinalini Dey ( @DrMiniDey) discusses abstract #1428 presented at the #ACR21 annual meeting.
https://t.co/E6RSlPAuRT https://t.co/QBhKD855aH
This podcast is devoted to discussing patient satisfaction and factors important in their willingness or unwillingness (resistance) to change therapies.
https://t.co/eVLlD8gEIM https://t.co/B24NWnGLHu
ICYMI: Type 1 and Type II Lupus — Patient Perspectives: Dr. Mehta ( @bella_mehta) interviews Dr. Clowse about abstract #1277 presented at the #ACR21 annual meeting
https://t.co/2w1Lwwhplf https://t.co/4sJR6DG0q0
ICYMI: JAKi Safety: Dr. Aurelie Najm ( @AurelieRheumo) interviews Dr. Choy about JAKi safety data, including abstracts #0958, #1940 and #1941 presented at the #ACR21 annual meeting.
https://t.co/LOM8zz62Pm https://t.co/83HRCZdtfE
ICYMI: Updates on New Treatments for SpA: Drs. Antoni Chan ( @synovialjoints) interviews Dr. Laura Coates discuss a number of studies related to new treatments for SpA presented at the #ACR21 annual meeting.
https://t.co/aCK1RRvTaW https://t.co/X1TlY88Jng
ICYMI: Perspectives on CV safety: JAK inhibitor (Tofacitinib) and TNF inhibitors
https://t.co/g5FirIK9Af https://t.co/63s7IaKhl7
ICYMI: Filgotinib (Jyseleca) was approved by European Commission approved for EU use in adults with moderately to severely active Ulcerative colitis (not responding to conventional therapy or a biologic). Rec based on Phase 2b/3 SELECTION trial. https://t.co/9VbCJse6Tr
ICYMI: An Old Friend – Methotrexate in Psoriatic Arthritis
Methotrexate (MTX) remains one of our most used and reliable tools against a variety of rheumatic diseases, particularly in the care of peripheral arthritis such as PsA.
https://t.co/kJdQ9Pd67v
#ACR21 @_Castillo_Pedro https://t.co/lpvZJaPcYd
Find all our #ACR21 podcast coverage here.
https://t.co/ZcWxysfoY1 https://t.co/mKOX4suJYi
ICYMI: Drs. Jack Cush and the RheumNow Faculty Drs. David Liew, Swetha Ann Alexander, Meral El Ramahi, Mrinalini Dey and Robert Chao, discuss highlights from Day 2 at the #ACR21 meeting.
https://t.co/ZaXlhyEKwY
@drdavidliew @swethaann23 @MeralElRamahiMD @DrMiniDey @doctorRBC https://t.co/TNEJUEIRc4
ICYMI: Emerging Therapies in Psoriatic Arthritis: Drs. Antoni Chan ( @synovialjoints) interviews Dr. FitzGerald about abstract #0490 and other PsA highlights being presented at the #ACR21 annual meeting.
https://t.co/1v8WhMkRHr https://t.co/UbqGkbupUM
This podcast is devoted to discussing patient satisfaction and factors important in their willingness or unwillingness (resistance) to change therapies.
https://t.co/QhjXkgW8f2 https://t.co/Zt8BxU0jVf
Geriatric Rheumatology:Improving care of aging patients
Dr.Kathryn Dao ( @KDAO2011) moderates a panel w/ Drs.Una Makris, Katherine Wysham, Sebastian Sattui + Devyani Misra, as they discuss aspects of improving care of/outcomes for aging patients. #ACR21
https://t.co/lF3yUZBEkd https://t.co/hYufA8ptqj
CBD and Opioids in Psoriatic Arthritis: Dr. Eric Ruderman ( @JointMD) reviews abstract #1456 and #1777 presented at the #ACR21 annual meeting.
https://t.co/QnjgjZ13Uq https://t.co/PdbMmcCoIH
Frailty in Lupus: Dr. Sheila Reyes ( @RHEUMarampa) reviews abstract #0869 presented at the #ACR21 annual meeting.
https://t.co/5jR74VQBeG https://t.co/AJIhR5Waip


